Tests
Human Parainfluenza Virus 2 Measurement
The determination of the amount of Human Parainfluenza Virus 2 in a sample.
Loading
Search products, companies, tests, and guides — go from query to quote request in one place.
Tests
The determination of the amount of Human Parainfluenza Virus 2 in a sample.
Tests
The determination of the amount of Human parainfluenza virus 2 RNA in a biological sample.
Indicators
This gene plays a role in intermediary metabolism.
Indicators
The second most abundant immunoglobulin G (IgG) subclass in the circulation of healthy individuals. The IgG2 core hinge sequence contains 12 amino acids and up to four interchain disulfide bonds. This subtype has low affinity for binding both Fc receptors and complement component C1q. The production of this IgG2 is stimulated by exposure to bacterial capsular polysaccharides and other antigenic glycans.
Tests
The determination of the amount of immunoglobulin G subclass 2 present in a sample.
Glossary Term
Validation evidence that an assay detects the range of variants, genotypes, or serotypes it claims to cover. For evolving targets such as influenza or SARS-CoV-2, inclusivity statements carry a validation date and should be checked against circulating variant lists at procurement time.
Indicators
Molecular detection and typing of influenza A and B viruses.
Tests
The determination of the amount of insulin-like growth factor-2 present in a sample.
Tests
The determination of the amount of insulin-like growth factor binding protein 2 present in a sample.
Tests
The determination of the amount of interleukin 2 receptor subunit beta present in a sample.
Indicators
Interleukin-2 (153 aa, ~18 kDa) is encoded by the human IL2 gene. This protein is involved in T-cell proliferation, leukocyte stimulation and immune responses.
Tests
The determination of the ratio of the concentration of interleukin-2 receptor to the number of lymphocytes present in a biological sample. The measurement may be expressed as a ratio or percentage.